Replimune (REPL) Other financing activities (2018 - 2020)
Replimune's (REPL) quarterly Other financing activities came in at $100000.0 in Q4 2020, down 98.28% year-on-year from $5.8 million in Q1 2020, and up 101.39% quarter-over-quarter from -$7.2 million in Q3 2020.
Replimune (REPL) Other financing activities (2018 - 2020) Analysis & Trends
Replimune has disclosed Other financing activities across 3 years of filings, most recently posting $100000.0 for Q4 2020.
- Other financing activities for Q4 2020 came in at $100000.0, down 98.28% year-over-year; the trailing twelve-month figure through Sep 2021 was $100000.0 (down 98.28% YoY), and the FY2021 annual result was $100000.0, down 71.83% from the prior year.
- Other financing activities came in at $100000.0 for Q4 2020 at Replimune, up from -$7.2 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $9.9 million in Q3 2018 to a low of -$7.2 million in Q3 2020.
- The 3-year median for Other financing activities is $3.0 million (2018), against an average of $2.7 million.
- Peak annual rise in Other financing activities reached 98.28% in 2020, while the deepest fall reached 98.28% in 2020.
- Replimune's Other financing activities stood at $9.9 million in 2018, then slumped by 41.48% to $5.8 million in 2019, then sank by 98.28% to $100000.0 in 2020.
- The last three Other financing activities figures came in at $100000.0 (Q4 2020), -$7.2 million (Q3 2020), and $7.2 million (Q2 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Sep 30, 2020 | -7.22 Mn |
| Sep 30, 2020 | -7.22 Mn |
| Jun 30, 2020 | 7.22 Mn |
| Jun 30, 2020 | 7.22 Mn |
| Dec 31, 2019 | 5.81 Mn |
| Dec 31, 2019 | 5.81 Mn |
| Sep 30, 2018 | 9.94 Mn |
| Sep 30, 2018 | 9.94 Mn |
| Jun 30, 2018 | 195,000.00 |
| Jun 30, 2018 | 195,000.00 |